42a74ac9 E32a 4b9a 800f 1d3d5fdfc000 01
Capecitabine Tablet, Film Coated
Product Images NDC 69097-948
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Capecitabine (NDC 69097-948). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
42a74ac9 E32a 4b9a 800f 1d3d5fdfc000 02
42a74ac9 E32a 4b9a 800f 1d3d5fdfc000 03
42a74ac9 E32a 4b9a 800f 1d3d5fdfc000 04
42a74ac9 E32a 4b9a 800f 1d3d5fdfc000 05
Not available.*
42a74ac9 E32a 4b9a 800f 1d3d5fdfc000 06
42a74ac9 E32a 4b9a 800f 1d3d5fdfc000 07
42a74ac9 E32a 4b9a 800f 1d3d5fdfc000 08
NDC 69097-949-03 is a prescription drug called Capecitabine. It is available in the form of film-coated tablets, USP. Each tablet contains 150 mg of capecitabine. The usual dosage and storage instructions can be found in the package insert. The tablets should be stored at a temperature of 25°C (77°F) with excursions permitted between 15°-30°C (59°-86°F). It should be kept tightly closed in tight containers as defined in USP/NF. The drug is manufactured by MSN Laboratories Private Limited in Telangana, India, and distributed by Cipla USA, Inc. The revision date of the information is 09/07/2019. Additional details including GTIN, SIN, EXP, and LOT are over coded with 2D during packing in a coding area measuring 38 x 25 mm.*
42a74ac9 E32a 4b9a 800f 1d3d5fdfc000 09
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
